Molecular Partners AG at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome to the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan, and it's my great pleasure to host Patrick Amstutz, the CEO of Molecular Partners for this session. Before I hand over to Patrick for the presentation, I'd just remind everyone that they can ask their questions on the website for the conference, and then I'll ask them when we get to that part of the session. With that, Patrick, welcome to the conference. Good to see you. Over to you.
Thanks, Richard. And unfortunately, this is not in person. I was really very much planning to be at JPMorgan in San Francisco. That is a big -- it's very a -- shame that we can't do that. Our reason is clear. It's still COVID times. And part of my speech will be also be about that. With the benefit being, I think, it's one of the conferences where I'm leased jet lagged.
My name is Patrick
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |